A shrinking comany - Recensione dipendente - Executive Director presso Merck

2,0
4 feb 2019
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Stock is up because shifted to an Oncology and Vaccines company

Svantaggi

Senior leadership are generally poor leaders. Company reorganizes every year.

Esplora altre recensioni su Merck

5,0
9 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Pension plan is great with high proportion

Svantaggi

Slow promotion and too much meetings

4,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Svantaggi

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Vedi recensioni per: Utile|Valutazione|Data|Tutto